By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French life science firm Cytoo announced today that it, Cellectis Bioresearch, and the French Alternative Energies and Atomic Energy Commission (CEA) are partnering to develop cell-based assays for drug development and toxicology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.